What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Internal medicine
His scientific interests lie mostly in Cancer research, Cancer, PI3K/AKT/mTOR pathway, Signal transduction and Protein kinase B.
His research integrates issues of Mutation, Ovarian cancer, Breast cancer, Kinase and PTEN in his study of Cancer research.
Gordon B. Mills interconnects Carcinogenesis, Endocrinology, Ovary and Serous fluid in the investigation of issues within Ovarian cancer.
His Breast cancer research integrates issues from Immunohistochemistry and Gene expression profiling.
His Cancer study is associated with Genetics.
The Signal transduction study combines topics in areas such as Receptor, Cell cycle and Cell culture.
His most cited work include:
- Comprehensive molecular portraits of human breast tumours (7253 citations)
- Comprehensive molecular portraits of human breast tumours (7253 citations)
- Integrated genomic analyses of ovarian carcinoma (4769 citations)
What are the main themes of his work throughout his whole career to date?
Cancer research, Cancer, Internal medicine, Breast cancer and Oncology are his primary areas of study.
His Cancer research study combines topics from a wide range of disciplines, such as PI3K/AKT/mTOR pathway, Protein kinase B, Signal transduction, Cancer cell and Ovarian cancer.
His research in PI3K/AKT/mTOR pathway intersects with topics in Kinase and MAPK/ERK pathway.
As a part of the same scientific study, he usually deals with the Cancer, concentrating on Computational biology and frequently concerns with Gene.
His work in Triple-negative breast cancer and Estrogen receptor is related to Breast cancer.
His research in Cell biology intersects with topics in Cell growth, Apoptosis, Biochemistry, Receptor and Cell cycle.
He most often published in these fields:
- Cancer research (46.54%)
- Cancer (25.44%)
- Internal medicine (20.78%)
What were the highlights of his more recent work (between 2017-2021)?
- Cancer research (46.54%)
- Cancer (25.44%)
- Internal medicine (20.78%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Cancer research, Cancer, Internal medicine, Oncology and Computational biology.
His Cancer research study combines topics in areas such as Protein kinase B, Cancer cell, Ovarian cancer, Breast cancer and PI3K/AKT/mTOR pathway.
As part of the same scientific family, Gordon B. Mills usually focuses on Ovarian cancer, concentrating on PARP inhibitor and intersecting with G2-M DNA damage checkpoint.
In his study, Apoptosis is inextricably linked to Downregulation and upregulation, which falls within the broad field of Breast cancer.
His Cancer research includes elements of Mutation, Cell, Transcriptome and Combination therapy.
His research integrates issues of Proteome, Protein microarray and Genome, Gene, Proteomics in his study of Computational biology.
Between 2017 and 2021, his most popular works were:
- Comprehensive Characterization of Cancer Driver Genes and Mutations (867 citations)
- Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response (670 citations)
- Next-generation characterization of the Cancer Cell Line Encyclopedia (576 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Internal medicine
His primary areas of investigation include Cancer research, Cancer, Computational biology, Gene and Cancer cell.
His Cancer research research is multidisciplinary, relying on both DNA damage, Mutation, Apoptosis, Ovarian cancer and Drug resistance.
His work in Cancer addresses issues such as Protein kinase B, which are connected to fields such as Enzyme activator and Surgical oncology.
His Gene study integrates concerns from other disciplines, such as Targeted therapy and Pharmacogenomics.
His Cancer cell research includes themes of Carcinogenesis and Cell cycle.
As part of one scientific family, Gordon B. Mills deals mainly with the area of Carcinogenesis, narrowing it down to issues related to the Gene expression profiling, and often Breast cancer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
